ArticleBreast cancer research : BCR2026
Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.
Balazs Acs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.